PMID- 18070882 OWN - NLM STAT- MEDLINE DCOM- 20080331 LR - 20231105 IS - 0021-9258 (Print) IS - 1083-351X (Electronic) IS - 0021-9258 (Linking) VI - 283 IP - 6 DP - 2008 Feb 8 TI - Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis. PG - 3465-3475 LID - S0021-9258(20)69811-8 [pii] LID - 10.1074/jbc.M706643200 [doi] AB - mTORC1 is a complex of proteins that includes the mammalian target of rapamycin (mTOR) and several regulatory proteins. It is activated by a variety of hormones (e.g. insulin) and nutrients (e.g. amino acids) that act to stimulate cell growth and proliferation and repressed by hormones (e.g. glucocorticoids) that act to reduce cell growth. Curiously, mTORC1 signaling is reported to be rapidly (e.g. within 1-2 h) activated by inhibitors of protein synthesis that act on either mRNA translation elongation or gene transcription. However, the basis for the mTORC1 activation has not been satisfactorily delineated. In the present study, mTORC1 signaling was found to be activated in response to inhibition of either the initiation or elongation phases of mRNA translation. Changes in mTORC1 signaling were inversely proportional to alterations in the expression of the mTORC1 repressor, REDD1, but not the expression of TRB3 or TSC2. Moreover the cycloheximide-induced increase in mTORC1 signaling was significantly attenuated in cells lacking REDD1, showing that REDD1 plays an integral role in the response. Finally, the half-life of REDD1 was estimated to be 5 min or less. Overall, the results are consistent with a model in which inhibition of protein synthesis leads to a loss of REDD1 protein because of its rapid degradation, and in part reduced REDD1 expression subsequently leads to de-repression of mTORC1 activity. FAU - Kimball, Scot R AU - Kimball SR AD - Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 and the. Electronic address: skimball@psu.edu. FAU - Do, A N Dang AU - Do AND AD - Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 and the. FAU - Kutzler, Lydia AU - Kutzler L AD - Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 and the. FAU - Cavener, Douglas R AU - Cavener DR AD - Department of Biology, The Pennsylvania State University, University Park, Pennsylvania 16802. FAU - Jefferson, Leonard S AU - Jefferson LS AD - Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 and the. LA - eng GR - R01 DK013499/DK/NIDDK NIH HHS/United States GR - R01 DK013499-38/DK/NIDDK NIH HHS/United States GR - R01 DK013499-39/DK/NIDDK NIH HHS/United States GR - DK-13499/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20071210 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Cell Cycle Proteins) RN - 0 (Ddit4 protein, mouse) RN - 0 (Neuropeptides) RN - 0 (Phosphoproteins) RN - 0 (Protein Synthesis Inhibitors) RN - 0 (RNA, Messenger) RN - 0 (Ras Homolog Enriched in Brain Protein) RN - 0 (Rheb protein, mouse) RN - 0 (TRB3 protein, mouse) RN - 0 (Transcription Factors) RN - 0 (Tsc2 protein, mouse) RN - 0 (Tuberous Sclerosis Complex 2 Protein) RN - 0 (Tumor Suppressor Proteins) RN - 0 (proline-rich Akt substrate, 40 kDa protein, mouse) RN - 98600C0908 (Cycloheximide) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.6.5.2 (Monomeric GTP-Binding Proteins) SB - IM MH - Animals MH - Cell Cycle Proteins/metabolism MH - Cycloheximide/pharmacology MH - *Gene Expression Regulation MH - Mice MH - Mice, Transgenic MH - Models, Biological MH - Monomeric GTP-Binding Proteins/metabolism/*physiology MH - Neuropeptides/metabolism/*physiology MH - Phosphoproteins/metabolism/*physiology MH - Protein Biosynthesis MH - Protein Kinases/metabolism/*physiology MH - Protein Synthesis Inhibitors/pharmacology MH - RNA, Messenger/metabolism MH - Ras Homolog Enriched in Brain Protein MH - Signal Transduction MH - TOR Serine-Threonine Kinases MH - Transcription Factors/*physiology MH - Tuberous Sclerosis Complex 2 Protein MH - Tumor Suppressor Proteins PMC - PMC2654224 MID - NIHMS89144 EDAT- 2007/12/12 09:00 MHDA- 2008/04/01 09:00 PMCR- 2009/03/11 CRDT- 2007/12/12 09:00 PHST- 2007/12/12 09:00 [pubmed] PHST- 2008/04/01 09:00 [medline] PHST- 2007/12/12 09:00 [entrez] PHST- 2009/03/11 00:00 [pmc-release] AID - S0021-9258(20)69811-8 [pii] AID - 10.1074/jbc.M706643200 [doi] PST - ppublish SO - J Biol Chem. 2008 Feb 8;283(6):3465-3475. doi: 10.1074/jbc.M706643200. Epub 2007 Dec 10.